Cargando…

Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis

BACKGROUND: Microdeletion syndromes are generally identified because they usually give rise to specific phenotypic features; many of these deletions are mediated by duplicons or LCRs. The phenotypes associated with subtelomeric deletions are also becoming recognised. However, reciprocal duplication...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Joo Wook, Mann, Kathy, Docherty, Zoe, Mackie Ogilvie, Caroline
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375878/
https://www.ncbi.nlm.nih.gov/pubmed/18471307
http://dx.doi.org/10.1186/1755-8166-1-2
_version_ 1782154665450799104
author Ahn, Joo Wook
Mann, Kathy
Docherty, Zoe
Mackie Ogilvie, Caroline
author_facet Ahn, Joo Wook
Mann, Kathy
Docherty, Zoe
Mackie Ogilvie, Caroline
author_sort Ahn, Joo Wook
collection PubMed
description BACKGROUND: Microdeletion syndromes are generally identified because they usually give rise to specific phenotypic features; many of these deletions are mediated by duplicons or LCRs. The phenotypes associated with subtelomeric deletions are also becoming recognised. However, reciprocal duplication events at these loci are less easily recognised and identified, as they may give rise to milder phenotypic features, and the individuals carrying them may not therefore be referred for appropriate testing. 403 patients with developmental delay and/or dysmorphism, referred to our Genetics Centre for karyotyping and Fragile X expansion testing, were assessed for chromosome imbalance by Multiplex Ligation-dependent Probe Amplification (MLPA). Two MLPA kits were used, one containing probes for the subtelomere regions, and one containing probes for common microdeletion loci. 321 patients were tested with both kits, 75 with the subtelomere kit alone, and 7 with the microdeletion kit alone. RESULTS: 32 patients had abnormal results; the overall abnormality detection rate was 2.5% for karyotype analysis and 7.2% for MLPA testing; 5.5% of subtelomere tests and 2.1% of microdeletion tests gave abnormal results. Of the abnormal MLPA results, 5 were in cases with cytogenetically visible abnormalities; of the remaining, submicroscopic, changes, 3 results were established as de novo and 8 were inherited; parental samples were not available for the remaining cases. None of the patients was found to have a Fragile X expansion. CONCLUSION: Karyotype analysis in combination with MLPA assays for subtelomeres and microdeletion loci may be recommended for this patient group.
format Text
id pubmed-2375878
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23758782008-05-10 Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis Ahn, Joo Wook Mann, Kathy Docherty, Zoe Mackie Ogilvie, Caroline Mol Cytogenet Research BACKGROUND: Microdeletion syndromes are generally identified because they usually give rise to specific phenotypic features; many of these deletions are mediated by duplicons or LCRs. The phenotypes associated with subtelomeric deletions are also becoming recognised. However, reciprocal duplication events at these loci are less easily recognised and identified, as they may give rise to milder phenotypic features, and the individuals carrying them may not therefore be referred for appropriate testing. 403 patients with developmental delay and/or dysmorphism, referred to our Genetics Centre for karyotyping and Fragile X expansion testing, were assessed for chromosome imbalance by Multiplex Ligation-dependent Probe Amplification (MLPA). Two MLPA kits were used, one containing probes for the subtelomere regions, and one containing probes for common microdeletion loci. 321 patients were tested with both kits, 75 with the subtelomere kit alone, and 7 with the microdeletion kit alone. RESULTS: 32 patients had abnormal results; the overall abnormality detection rate was 2.5% for karyotype analysis and 7.2% for MLPA testing; 5.5% of subtelomere tests and 2.1% of microdeletion tests gave abnormal results. Of the abnormal MLPA results, 5 were in cases with cytogenetically visible abnormalities; of the remaining, submicroscopic, changes, 3 results were established as de novo and 8 were inherited; parental samples were not available for the remaining cases. None of the patients was found to have a Fragile X expansion. CONCLUSION: Karyotype analysis in combination with MLPA assays for subtelomeres and microdeletion loci may be recommended for this patient group. BioMed Central 2008-03-26 /pmc/articles/PMC2375878/ /pubmed/18471307 http://dx.doi.org/10.1186/1755-8166-1-2 Text en Copyright © 2008 Ahn et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ahn, Joo Wook
Mann, Kathy
Docherty, Zoe
Mackie Ogilvie, Caroline
Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis
title Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis
title_full Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis
title_fullStr Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis
title_full_unstemmed Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis
title_short Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis
title_sort submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for fragile x testing and karyotype analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375878/
https://www.ncbi.nlm.nih.gov/pubmed/18471307
http://dx.doi.org/10.1186/1755-8166-1-2
work_keys_str_mv AT ahnjoowook submicroscopicchromosomeimbalanceinpatientswithdevelopmentaldelayandordysmorphismreferredspecificallyforfragilextestingandkaryotypeanalysis
AT mannkathy submicroscopicchromosomeimbalanceinpatientswithdevelopmentaldelayandordysmorphismreferredspecificallyforfragilextestingandkaryotypeanalysis
AT dochertyzoe submicroscopicchromosomeimbalanceinpatientswithdevelopmentaldelayandordysmorphismreferredspecificallyforfragilextestingandkaryotypeanalysis
AT mackieogilviecaroline submicroscopicchromosomeimbalanceinpatientswithdevelopmentaldelayandordysmorphismreferredspecificallyforfragilextestingandkaryotypeanalysis